A series of alisol A derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activities and cytotoxicities in vitro. The preliminary investigation demonstrates that simple modifications of the parent structure of alisol A can produce a number of potentially important derivatives against HBV. The most active anti-HBV compound 6a showed high activities against the secretion
合成了一系列alisol A衍
生物,并对其抗乙型肝炎病毒(HBV)活性和体外细胞毒性进行了评估。初步研究表明,简单修饰alisol A的母体结构可以产生许多潜在的抗HBV重要衍
生物。最具活性的抗HBV化合物6a对HBV表面抗原(IC(50)= 0.024 mM),HBV e抗原(IC(50)= 0.028 mM)的分泌具有很高的活性,并且具有显着的选择性指数(SI(HBsAg)> 108,SI(HBeAg)> 93),被选作新型HBV
抑制剂作进一步评估。